Mrozek J D, Smith K M, Simonton S C, Bing D R, Meyers P A, Connett J E, Mammel M C
Infant Pulmonary Research Center, Children's Health Care of St. Paul, MN 55102, USA.
Crit Care Med. 1999 Sep;27(9):1916-22. doi: 10.1097/00003246-199909000-00033.
To test the hypothesis that perfluorocarbon (PFC) priming before surfactant administration improves gas exchange and lung compliance, and also decreases lung injury, more than surfactant alone.
Prospective, randomized animal study.
Animal research laboratory of Children's Hospital of St. Paul.
Thirty-two newborn piglets, weighing 1.55 +/- 0.18 kg.
We studied four groups of eight animals randomized after anesthesia, paralysis, tracheostomy, and establishment of lung injury using saline washout to receive one of the following treatments: a) surfactant alone (n = 8); b) priming with the PFC perflubron alone (n = 8); c) priming with perflubron followed by surfactant (n = 8); and d) no treatment (control; n = 8). Perflubron priming was achieved by instilling perflubron via the endotracheal tube in an amount estimated to represent the functional residual capacity, ventilating the animal for 30 mins, and then removing perflubron by suctioning. After all treatments were given, animals were mechanically ventilated for 4 hrs.
We evaluated oxygenation, airway pressures, respiratory system compliance, and hemodynamics at baseline, after induction of lung injury, and at 30-min intervals for 4 hrs. Histopathologic evaluation was carried out using a semiquantitative scoring system and by computer-assisted morphometric analysis. After all treatments, animals had decreased oxygenation indices (p < .001) and increased respiratory system compliance (p < .05). Animals in PFC groups had similar physiologic responses to treatments as animals treated with surfactant only; both the PFC-treated groups and the surfactant-treated animals required lower mean airway pressures throughout the experiment (p < .001) and had higher pH levels at 90 and 120 mins (p < .05) compared with the control group. Pathologic analysis demonstrated decreased lung injury in surfactant-treated animals compared with animals treated with PFC or the controls (p < .02).
Priming the lung with PFC neither improved the physiologic effects of exogenous surfactant nor improved lung pathology in this animal model.
验证以下假说,即与单独使用表面活性剂相比,在给予表面活性剂之前用全氟碳化合物(PFC)进行预充可改善气体交换和肺顺应性,并减少肺损伤。
前瞻性随机动物研究。
圣保罗儿童医院动物研究实验室。
32头新生仔猪,体重1.55±0.18千克。
我们研究了四组动物,每组8只,在麻醉、麻痹、气管切开并通过盐水冲洗造成肺损伤后进行随机分组,接受以下治疗之一:a)单独使用表面活性剂(n = 8);b)仅用全氟溴烷进行预充(n = 8);c)先用全氟溴烷预充,然后使用表面活性剂(n = 8);d)不进行治疗(对照组;n = 8)。通过经气管内导管滴注全氟溴烷来实现全氟溴烷预充,滴注量估计相当于功能残气量,对动物进行30分钟通气,然后通过抽吸清除全氟溴烷。给予所有治疗后,对动物进行4小时机械通气。
我们在基线、诱导肺损伤后以及4小时内每隔30分钟评估氧合、气道压力、呼吸系统顺应性和血流动力学。使用半定量评分系统并通过计算机辅助形态计量分析进行组织病理学评估。所有治疗后,动物的氧合指数降低(p <.001),呼吸系统顺应性增加(p <.05)。PFC组动物对治疗的生理反应与仅接受表面活性剂治疗的动物相似;与对照组相比,PFC治疗组和表面活性剂治疗动物在整个实验过程中均需要较低的平均气道压力(p <.001),并且在90和120分钟时pH值较高(p <.05)。病理分析表明,与接受PFC治疗或对照的动物相比,表面活性剂治疗的动物肺损伤减少(p <.02)。
在该动物模型中,用PFC对肺进行预充既未改善外源性表面活性剂的生理作用,也未改善肺病理学情况。